Selatinib is a potent dual EGFR/HER-2 inhibitor. It is an analog of quinazoline lapatinib and has potential antitumor activity.

1275595-86-2

C29H26ClFN4O3S

565.06

Selatinib

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years